Registered Kenya · PPB

VIGOSINE

CARNITINE HYDROCHLORIDE

What it does

Carnitine is a substance that helps your body use fat for energy and is often taken as a supplement.

Commonly used for: fatigue, muscle weakness, heart disease (cardiomyopathy)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
660
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CARNITINE HYDROCHLORIDE
Strength
-
Pack size
-
Therapeutic class
-
RxNorm RxCUI
2106
Manufacturer / MAH
Oriana
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Al Khan - Sharjah - United Arab Emirates

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:29:06 · updated 2026-07-20 11:03:14

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Carnitine is a substance that helps your body use fat for energy and is often taken as a supplement.

What it treats

  • fatigue
  • muscle weakness
  • heart disease (cardiomyopathy)

How it works

Carnitine helps transport fatty acids into the cells, where they can be used for energy.

Who it's for

Carnitine can be used by people experiencing fatigue or muscle weakness, and those with certain heart conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: carnitine

BNF-referenced

Carnitine is a quaternary ammonium compound derived from the amino acids lysine and methionine. It plays a crucial role in the transport of fatty acids into the mitochondria for β-oxidation and energy production. It is naturally synthesized in the body and is predominantly found in tissues with high rates of fatty acid oxidation, such as skeletal and cardiac muscle. Carnitine supplementation is used in clinical settings to address deficiencies and support energy metabolism.

Indications

  • Primary carnitine deficiency
  • Secondary carnitine deficiency (e.g., due to certain metabolic disorders)
  • Certain conditions associated with impaired fatty acid oxidation
  • Supportive treatment in patients with heart disease or metabolic syndrome

Dosage

Children: Refer to BNF for Children for specific dosing recommendations based on the child's condition and age.

Adults: Refer to BNF for specific dosing recommendations based on the condition being treated.

Mechanism of action

Carnitine facilitates the transport of long-chain fatty acids across the mitochondrial membrane by forming acyl-carnitine derivatives. This process is essential for the β-oxidation of fatty acids, enabling their conversion into acetyl-CoA, which enters the citric acid cycle to produce ATP. Additionally, carnitine plays a role in the removal of toxic acyl groups from the mitochondria, thus helping to detoxify the cell.

Pharmacodynamics

Carnitine enhances fatty acid oxidation and energy production in tissues that rely heavily on fat as a fuel source. It helps maintain cellular energy homeostasis, supports metabolic functions, and may have protective effects against oxidative stress by improving mitochondrial function.

Pharmacokinetics

Carnitine is absorbed in the gastrointestinal tract, with peak plasma concentrations typically occurring within 3-5 hours post-ingestion. It is distributed widely in body tissues, with high concentrations found in skeletal and cardiac muscle. Carnitine is primarily excreted in the urine as free carnitine and acyl-carnitine derivatives. The half-life of carnitine in plasma is approximately 2-3 hours, and its levels can be influenced by dietary intake and renal function.

Adverse effects

  • Nausea
  • Vomiting
  • Abdominal cramps
  • Diarrhea
  • Fishy body odor

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for changes in renal function

Pregnancy

Safety in pregnancy has not been established.

Breast-feeding

Carnitine is excreted in breast milk; use caution.

Storage

Store in a cool, dry place, protected from light.

Formulations

  • Carnitine oral solution
  • Carnitine tablets

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: carnitine

PubChem CID 288

Molecular formula: C7H15NO3

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.